CERE - Cerevel Therapeutics Holdings, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
136,521
193,018
383,623
79,551
Other short-term investments
755,509
372,670
-
-
Total cash
892,030
565,688
383,623
79,551
Other current assets
13,621
12,329
6,937
69
Total current assets
905,651
578,017
390,560
87,077
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
49,287
51,700
48,624
27,673
Accumulated depreciation
-7,259
-2,566
-82
-182
Net property, plant and equipment
49,287
51,700
48,624
27,491
Equity and other investments
58,126
52,269
-
-
Other long-term assets
4,758
6,933
6,089
4,753
Total non-current assets
112,171
110,902
54,713
33,729
Total assets
1,017,822
688,919
445,273
120,806
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
10,061
11,298
4,993
2,109
Accrued liabilities
39,404
28,803
22,519
6,475
Other current liabilities
1,143
375
273
74
Total current liabilities
72,564
42,538
29,548
14,876
Non-current liabilities
Long-term debt
335,482
-
-
-
Other long-term liabilities
57,348
33,542
236
2,028
Total non-current liabilities
424,020
67,652
31,205
28,107
Total liabilities
496,584
110,190
60,753
42,983
Stockholders' equity
Common stock
16
15
13
6
Retained earnings
-967,755
-616,244
-390,910
-244,298
Accumulated other comprehensive income
3,097
-986
-
-
Total stockholders' equity
521,238
578,729
384,520
77,823
Total liabilities and stockholders' equity
1,017,822
688,919
445,273
120,806